Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
life sciences
3
×
national blog main
national top stories
new york blog main
new york top stories
clinical trials
new york
regeneron pharmaceuticals
san francisco blog main
san francisco top stories
abbvie
acorda therapeutics
alex azar
alirocumab
american patients first
amgen
ampyra
apokyn
apomorphine
biosimilars
biotech
boulder/denver blog main
boulder/denver top stories
center for medicare and medicaid services
cholesterol
craig garthwaite
cvs health
dalfampridine
data
department of health and human services
detroit blog main
detroit top stories
donald trump
drug prices
duopa
express scripts
fda
food and drug administration
What
drug
meant
3
×
aces
acorda
afternoon
announced
anticipated
approved
awaited
big
blueprint
ceo
cholesterol
cope
cost
cut
details
disease
drugs
episodes
fda
flexible
friday
gets
help
house
inclisiran
key
late
long
looms
lower
lowering
medco
medications
medicine
medicines
nasdaq
new
nod
Language
unset
Current search:
meant
×
" life sciences "
×
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Trump Pledges Lower Drug Prices, But Blueprint Is Short on Details
